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Abstract
Background: Elucidating the role of gut microbiota in physiological and pathological processes has recently emerged
as a key research aim in life sciences. In this respect, metaproteomics, the study of the whole protein complement of a
microbial community, can provide a unique contribution by revealing which functions are actually being expressed by
specific microbial taxa. However, its wide application to gut microbiota research has been hindered by challenges in
data analysis, especially related to the choice of the proper sequence databases for protein identification.
Results: Here, we present a systematic investigation of variables concerning database construction and annotation and
evaluate their impact on human and mouse gut metaproteomic results. We found that both publicly available
and experimental metagenomic databases lead to the identification of unique peptide assortments, suggesting
parallel database searches as a mean to gain more complete information. In particular, the contribution of experimental
metagenomic databases was revealed to be mandatory when dealing with mouse samples. Moreover, the use of a
“merged” database, containing all metagenomic sequences from the population under study, was found to be generally
preferable over the use of sample-matched databases. We also observed that taxonomic and functional results
are strongly database-dependent, in particular when analyzing the mouse gut microbiota. As a striking example,
the Firmicutes/Bacteroidetes ratio varied up to tenfold depending on the database used. Finally, assembling reads
into longer contigs provided significant advantages in terms of functional annotation yields.
Conclusions: This study contributes to identify host- and database-specific biases which need to be taken into
account in a metaproteomic experiment, providing meaningful insights on how to design gut microbiota studies
and to perform metaproteomic data analysis. In particular, the use of multiple databases and annotation tools
has to be encouraged, even though this requires appropriate bioinformatic resources.
Keywords: Bioinformatics, Gut microbiota, Mass spectrometry, Metagenomics, Metaproteomics
Background
The interest in studying the gut microbiota has seen a
tremendous rise over the past years, due to the increasing
recognition of its involvement in a wealth of physiological
functions and multifactorial diseases [1]. Consequently,
gut microbiota research is shifting from a mere descrip-
tion of the taxonomic distribution to a more comprehen-
sive exploration of a functional potential and activity of
the microbial community [2, 3]. To this purpose, metapro-
teomics, i.e., the study of the whole protein complement
of a microbial community, can reveal which functions are
actually being expressed by the gut microbiota in response
to host, diet, or other environmental stimuli [4–6].
In spite of the recent development of dedicated tools
enabling the reliable and integrated detection of taxonomic
and functional features of a metaproteome, metaproteomic
data analysis remains a challenge [7–9]. One of its most
critical steps is the choice of proper protein databases
(DBs) for the identification of mass spectra. Protein identifi-
cation, in fact, essentially relies on matching experimental
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mass spectra, generated from the sample under study, with
theoretical spectra, typically generated in silico from a se-
quence DB. Since a gut microbiota may contain up to over
a thousand different microbial species, and its composition
can vary considerably among individuals, the selection of a
well-suited DB is rather challenging. In addition, the use of
large sequence search spaces, without any prior restriction
to selected sequences/taxa, poses several FDR-related issues
which impair the identification rate [10, 11]. Even more
importantly, despite the impressive efforts undertaken in
human metagenome research, for most microbial species
inhabiting the gut of higher animals few or no protein se-
quences are present in public repositories [1]. Cross-species
identification is often possible, owing to the high sequence
similarity among orthologous genes from closely related
microorganisms [12], but a single amino acid change is
sufficient to hamper peptide-to-spectrum matching,
making protein identification impossible. Iterative and
error-tolerant DB searches, as well as DB-independent
de novo (peptide) sequencing, have been proposed as
improvements or alternatives to classical DB search
[11, 13–16]. However, an optimized and standardized
mass spectrometry (MS) data analysis pipeline for
metaproteomics is not yet available.
An alternative way to enhance sensitivity of metaproteo-
mic analysis builds on its specific integration with metage-
nomics, which can be established at different levels: first,
when the taxonomic structure of the microbiota under
study is known (typically based on 16S rDNA gene sequen-
cing data), a “pseudo-metagenome” can be assembled, that
is, a DB containing all publicly available sequences for the
taxa that are predicted to form that particular microbiota
[17, 18]; second, if metagenome sequences can be obtained
for all, or a subset of, the samples under study, these can be
translated, annotated, and used as DB. A few recent studies
tried to explore and benchmark these integration strategies,
focusing on metagenomes from human fecal samples
obtained using the 454 sequencing technology [19], or on
mock microbial mixtures analyzed by means of the Illu-
mina sequencing technology [15]. However, a systematic
investigation aimed at elucidating the influence of pro-
cessing, combination and, most importantly, taxonomic
and functional annotation of metagenomics-based DB
sequences on gut metaproteomic results is still lacking.
In keeping with this, we describe a systematic evalu-
ation of the impact of sequence DBs on gut metaproteo-
mic results, providing useful insights on how to design
gut microbiota studies. In particular, we aim to investigate:
(i) what is the best strategy between using experimental
metagenomic and publicly available DBs, and to what ex-
tent their outcomes are different; (ii) when constructing a
metagenomic DB, if sequence assembly into contigs pro-
vides additional information in comparison with unassem-
bled reads; (iii) if different DB types provide different
yields/outcomes in terms of taxonomic and functional
annotation; and (iv) if the answers to the previous questions
change when analyzing stool samples from mouse models
instead of from human patients/volunteers. By tackling
these issues, we seek to identify biases and critical points in
metaproteomic data analysis, which need to be taken into
consideration when planning metaproteomic experiments
in the context of large cross-sectional studies involving
human subjects or animal models.
Results
Experimental metagenomic databases and UniProt-based
databases lead to identification of different gut microbiota
peptide assortments
The main aim of this study was to perform a systematic
comparison of the main DB types which can be used in
a metaproteomic study, according to both sequencing-
based and sequencing-independent approaches. To this
purpose, we chose to conduct a preliminary investigation
of the impact of several DB construction variables using
a single human stool sample. Hence, as illustrated in
Fig. 1, the fecal material collected from a healthy human
volunteer was split into two equal portions, to be processed
in parallel according to a metagenomic and a metaproteo-
mic approach, and therefore to generate a wide gamut of
sequence DBs. In total, we generated 19 different DBs,
whose characteristics are presented in Table 1. Among
them, 12 were experimental metagenomic DBs (i.e., ob-
tained by metagenomic sequencing of the same individual
and analyzed by metaproteomics; MG-DBs), differing based
on common sequencing and sequence processing variables,
namely sequencing depth, read assembly level, and ORF
finding method; three were “pseudo-metagenomes”, con-
taining UniProt sequences taxonomically filtered based on
16S-rDNA sequencing data at thee different taxonomic
levels (species, genus, and family); four were sequencing-
independent DBs, with the first comprising the entire set of
bacterial sequences deposited in UniProt (UP-B) at the time
of the analysis, and the remaining three constructed
according to a previously described taxonomy-based
proteomic iterative (PI) strategy [15, 20] (see Methods
for further details). MS data obtained from the human
stool sample were then searched against all sequence
DBs in parallel using three different bioinformatics
platforms and two FDR thresholds (namely, 1 and
5 %), in order to rule out potential search engine- or
statistics-based biases.
Peptide identification metrics obtained with all se-
quence DBs are comparatively shown in Fig. 2. Concern-
ing open reading frame (ORF) finding methods and read
assembly level, six-frame translation did not provide
significant advantages over FragGeneScan, while read-
based MG-DBs slightly outperformed contig-based ones,
although the latter provided a specific contribution in
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unique peptides (Additional file 1: Figure S1). Taxonomic
filters at family and genus levels performed clearly better
than those at species level for all UniProt-based DBs
(Additional file 2: Figure S2). Overall, regardless of the
bioinformatics platform used, MG-DBs performed better
than UniProt-based DBs. Moreover, sequencing depth was
observed to have a linear relationship with MG-DBs met-
rics, with a stronger impact on contig-based DBs. How-
ever, each DB family provided a significant percentage of
unique peptides (up to over 50 %; Fig. 2b and Additional
file 3: Figure S3).
UniProt-based databases show severe limitations for gut
metaproteomics of mouse models, but not of human
subjects
A number of experimental mice models have been
exploited to date, enabling the simulation of extreme
changes in the microbiota. Environmental and genetic
effects are responsible for taxonomic differences between
the gut microbiome of mice raised in different laboratory
and/or obtained by different vendors [21, 22]. Hence, the
gut microbiota of a given experimental group of mice can
include subsets of bacterial species and strains with no or
poor sequencing background in public DBs, particularly at
low taxonomic levels. We therefore extended our meta-
proteogenomic analysis to mouse stool samples. Based on
the aforementioned preliminary results, we decided to
focus on three main DB types (namely, reads- and contig-
based MG-DBs and UP-B), keeping sequencing depth
(6 Gb), ORF finding method (FragGeneScan), search
engine (Sequest-HT), and FDR threshold (1 % according
to Percolator) unvaried. For both humans and mice, we
analyzed a small population (three samples per host spe-
cies), in order to take individual variability into account.
Each stool sample was split into two portions of equal size
and subjected in parallel to metagenomic and metaproteo-
mic analyses, as described above. MG-DBs were con-
structed by merging all sequences from each population
(DB characteristics are provided in Table 1).
As a striking result, for all mouse samples, UP-B per-
formed dramatically worse than MG-DBs, while the num-
ber of identified peptides between the two DB families were
similar in human samples (Fig. 3a). Again, each DB type
provided a significant amount of unique peptides in both
species, confirming multiple DB searches as a mean to con-
siderably increase the number of peptide identifications.
Databases merging sequences from different individuals
lead to higher peptide identification yields when
compared to sample-matched databases
The time-consuming and costly generation of MG-DBs
requires the careful evaluation of options aimed at
reducing the number of metagenomic sequencing runs
in any metaproteomic study. Therefore, given the
availability of metagenomic sequences from each of the
human and mice samples, we addressed the question
on whether using a sample-matched DB (i.e., the gut
metagenome of the very same subject analyzed by
metaproteomics)—as suggested by previous studies
[19]—could represent a better strategy than using a
Fig. 1 Design of the human stool sample experiment. Database-related acronyms contained into colored cylinders correspond to those indicated in Fig. 2
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larger DB containing all metagenomic sequences from
the population under study. Further, we sought to de-
termine if using a sample-matched DB could provide
significant advantages on using another gut metagen-
ome from the same population (i.e., an “unmatched”
DB). As shown in Fig. 3b, both sample-matched and
unmatched DBs provided a significantly lower amount
of peptide identifications when compared to the DBs
containing all metagenomic sequences from the popu-
lation (both for human and mouse); moreover, the
sample-matched DB significantly outperformed the
corresponding unmatched DB only when comparing
human read-based MG-DBs (for the other DB types,
the slight differences measured were not significant).
Table 1 Characteristics of sequence databases used in this study
Source Depth Sample Type Further information Sequences
UniProt Bacteria 72,669,092
UniProt Bacteria Human_0 16S Family 3,590,268
UniProt Bacteria Human_0 16S Genus 2,422,588
UniProt Bacteria Human_0 16S Species 610,219
UniProt Bacteria Human_0 PI Family—MPA 3,095,210
UniProt Bacteria Human_0 PI Genus—MPA 2,317,980
UniProt Bacteria Human_0 PI Species—MPA 178,908
UniProt Bacteria Human_0 PI Family—MQ 2,717,146
UniProt Bacteria Human_0 PI Genus—MQ 2,162,216
UniProt Bacteria Human_0 PI Species—MQ 190,367
UniProt Bacteria Human_0 PI Family—PD 3,173,395
UniProt Bacteria Human_0 PI Genus—PD 2,602,972
UniProt Bacteria Human_0 PI Species—PD 225,013
Metagenome 18 Mbps Human_0 Reads FragGeneScan 5,130,156
Metagenome 18 Mbps Human_0 Reads Six-frame translation 27,651,587
Metagenome 18 Mbps Human_0 Contigs FragGeneScan 224,163
Metagenome 18 Mbps Human_0 Contigs Six-frame translation 4,353,453
Metagenome 6 Mbps Human_0 Reads FragGeneScan 3,423,708
Metagenome 6 Mbps Human_0 Reads Six-frame translation 18,350,764
Metagenome 6 Mbps Human_0 Contigs FragGeneScan 192,582
Metagenome 6 Mbps Human_0 Contigs Six-frame translation 3,205,893
Metagenome 3 Mbps Human_0 Reads FragGeneScan 3,294,112
Metagenome 3 Mbps Human_0 Reads Six-frame translation 17,340,365
Metagenome 3 Mbps Human_0 Contigs FragGeneScan 109,233
Metagenome 3 Mbps Human_0 Contigs Six-frame translation 2,447,096
Metagenome 6 Mbps Human_1 Contigs FragGeneScan 101,903
Metagenome 6 Mbps Human_1 Reads FragGeneScan 1,288,040
Metagenome 6 Mbps Human_2 Contigs FragGeneScan 97,532
Metagenome 6 Mbps Human_2 Reads FragGeneScan 953,147
Metagenome 6 Mbps Human_3 Contigs FragGeneScan 60,517
Metagenome 6 Mbps Human_3 Reads FragGeneScan 625,354
Metagenome 6 Mbps Mouse_1 Contigs FragGeneScan 14,743
Metagenome 6 Mbps Mouse_1 Reads FragGeneScan 510,364
Metagenome 6 Mbps Mouse_2 Contigs FragGeneScan 88,366
Metagenome 6 Mbps Mouse_2 Reads FragGeneScan 600,697
Metagenome 6 Mbps Mouse_3 Contigs FragGeneScan 18,112
Metagenome 6 Mbps Mouse_3 Reads FragGeneScan 329,261
Tanca et al. Microbiome  (2016) 4:51 Page 4 of 13
According to these findings, reads- and contig-based
MG-DBs containing all metagenomic sequences from
the population and UP-B were selected for all subse-
quent analyses.
Taxonomic annotation in mouse gut metaproteomics shows
strong database- and classification algorithm-dependent
biases
As a further step, we performed taxonomic annotation
by means of two established tools which employ a lowest
common ancestor (LCA) algorithm: first, MEGAN was
used to carry out LCA classification of read, contig, and
protein sequences (identified from each respective DB)
based on results of sequence alignment versus NCBI-nr
entries; second, Unipept was employed to perform LCA
classification of tryptic peptide sequences (obtained from
each DB search) based on full homology with UniProt
entries. As shown in Fig. 4a, UP-B generally provided a
poorer annotation performance compared to MG-DBs,
with small differences in humans and greater disparity in
mice (especially down to the order level). Moreover,
when focusing on MG-DBs, a global decrease in peptide
annotation yield was found in mouse when compared to
human samples. Concerning the annotation tools, MEGAN
reached higher taxonomic annotation yields compared to
Unipept, for both host species and all DB types. A strong
Fig. 2 Peptide identification metrics in human gut metaproteomic data obtained using different databases. a Non-redundant peptides identified
by searching the MS spectra obtained from a human stool sample against 19 different types of sequence DBs. Each graph illustrates the results
achieved using a different bioinformatic platform, namely (from left to right) MetaProteomeAnalyzer (MPA), MaxQuant (MQ), and Proteome Discoverer (PD).
RF and R6 (in blue) represent sequence DBs based on metagenomic reads processed by FragGeneScan or six-frame translation, respectively, while CF and
C6 (in red) represent sequence DBs based on metagenomic assembled contigs processed by FragGeneScan or six-frame translation, respectively; 18, 6, and
3 are referred to the sequencing depth (in gigabases). Data from UniProt-based DBs are depicted in green (“pseudo-metagenomes” based on taxa found
by 16S rDNA gene analysis), orange (sequences selected based on taxa found by a proteomic iterative approach, PI; see Methods for further
details), and turquoise (all bacterial sequences); F, G and S are referred to the level of taxonomic filtering (family, genus, and species, respectively). Each
column in the histograms contains a darker (identifications with FDR <1 %) and a lighter part (additional identifications with FDR <5 %). b Total
peptide identifications obtained using five representative DBs and related multiple DB searches (ampersand indicates merging results from different DBs).
All searches were run in triplicate using the three abovementioned bioinformatic platforms
Fig. 3 Peptide identification metrics in human and mouse gut metaproteomic data obtained using different databases. a Results obtained with
human (N = 3, left) and mouse (N = 3, right) samples, with each dot representing a single sample. R-A and C-A are referred to DBs constructed
with metagenomic reads and contigs from all samples, respectively. UP-B indicates a UniProt-based DB containing all bacterial entries. Ampersand
indicates merging results from parallel DB searches. Asterisks indicate significantly different peptide identification yields between DBs (*p < 0.05;
**p < 0.01; ***p < 0.001; paired t test), with the asterisk color corresponding to the DB to which the comparison is referred (e.g., the green asterisk
over blue dots indicates significance of the difference between “R-A” and “R-A & UP-B”). b Comparison of metagenomic DB construction strategies
applied to human (N = 3, left) and mouse (N = 3, right) samples, with each dot representing a single sample. “R” and “C” refer to reads (blue) and
contigs (red), respectively. Matched DBs (sequences from the gut metagenome of the same subject analyzed by metaproteomics) are indicated
with “-M,” unmatched DBs (sequences from a gut metagenome of another subject of the same host species) are indicated with “-UM;” merged
DBs (sequences from gut metagenomes of all subjects analyzed for that host species) are indicated with “-A.” *p < 0.05 (paired t test)
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impact of sequence length could be also observed for
MEGAN, with the contig-based DBs (average sequence
length of 209 and 344 amino acids in humans and mice, re-
spectively) significantly outperforming the read-based DBs
(average sequence length of 48 and 45 amino acids in
humans and mice, respectively). Alpha-diversity calculation
also revealed DB- and annotation tool-dependent biases
(Additional file 4: Figure S4). MEGAN classification consid-
erably enhanced the divergence between human (higher)
and mouse (lower) gut metaproteome alpha-diversity, and
generally higher alpha-diversity values were retrieved from
Unipept data compared to MEGAN results. Even more in-
triguingly, according to the principal component analysis
(PCA) of taxa abundances, human and mouse data clus-
tered in a completely different fashion, namely according to
individuals and to DBs, respectively (Fig. 4b). This clearly
indicates a strong DB-dependent bias in taxonomic annota-
tion of mouse gut metaproteomic data.
Metaproteomic Firmicutes/Bacteroidetes ratios are
considerably influenced by the sequence database
type used
Taxa abundances were then subjected to LEfSe differential
analysis, in order to find taxa specifically enriched/depleted
when using a particular DB type. To gain insight into the
differential taxonomic information achievable with each
DB, we distinguished between “qualitatively differential
taxa” (i.e., always present when using a given DB and com-
pletely absent when using another DB) and “quantitatively
differential taxa” (i.e., all the remaining differential taxa). As
a result (Additional file 5: Figure S5), the mean amount of
taxa significantly changing in abundance when using differ-
ent DBs was dramatically higher in mice than in humans
(61 vs. 16 % with MEGAN, 25 vs. 2 % with Unipept, re-
spectively). Furthermore, the percentage of taxa consist-
ently identified with MG-DBs in all subjects and never
detected with UP-B, according to Unipept classification,
was null in human and 15 % in mouse samples (0.5 and
3 % with MEGAN, respectively), with over 30 taxa uniquely
detected with the contig-based DB. Hierarchical representa-
tion of differential taxa (graphically presented in clado-
grams of Additional file 6: Figure S6 and Additional file 7:
Figure S7) revealed, again, few and reproducible distinctions
in humans, counterbalanced by massive DB- and annota-
tion tool-dependent biases in mice, involving (especially for
MEGAN data) all main gut bacterial taxa, from phyla down
to species. We finally took into account the Firmicutes/Bac-
teroidetes ratio, whose longitudinal change has been estab-
lished as a synthetic measure of eubiosis/dysbiosis state
within the gut microbiota [23, 24]. As illustrated in Fig. 5,
we found a DB-related bias significantly influencing this
parameter not only in mouse but also in human results,
especially—and dramatically—when comparing UP-B
to MG-DBs (up to tenfold higher ratio, when applying
MEGAN to mouse data).
Functional annotation of the mouse gut metaproteome is
database-dependent
Finally, we focused on the functional annotation of
metaproteomic data. In a preliminary test, we obtained a
generally better functional annotation performance (in
terms of absolute and relative amount of entries with
Fig. 4 Taxonomic annotation of human and mouse gut metaproteomic data obtained using different databases. DBs were made up of reads
(dark blue, R-A) or contigs (red, C-A) from gut metagenomes of all subjects analyzed for each host species, or all bacterial sequences deposited in
UniProt (turquoise, UP-B). The annotation tools used were MEGAN (MEG) and Unipept (Up). a Histograms showing the mean number (N = 3, with
error bar indicating standard error of the mean) of non-redundant peptides identified (tot) and annotated at different taxonomic levels (p phylum;
c class; o order; f family; g genus; s species) in human (left) and mouse (right) samples. b PCA plots of taxa abundances, with each dot indicating a
different human (left) or mouse (right) subject
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complete annotation, at several levels) when blasting se-
quences against bacterial entries from Swiss-Prot, rather
than blasting against the whole UniProt (i.e., Swiss-Prot
+TrEMBL) DB, or retrieving KEGG or SEED functional
information from MEGAN (data not shown). Functional
information was therefore retrieved from Swiss-Prot. As
shown in Fig. 6a, the contig-based DB significantly out-
performed the read-based DB in terms of peptide anno-
tation yield, while UP-B behaved slightly worse than the
contig-based DB in human, and dramatically worse than
both MG-DBs in mouse. Consistently with taxonomic
data, human function abundances clustered according to
individuals, whereas mouse data clustered according to
the DB used (PCA plots in Fig. 6b). Furthermore, LEfSe
differential analysis revealed that up to 15 and 39 % of
the identified functions varied significantly when using
different DB types in human and mouse, respectively
(Additional file 8: Figure S8 and Additional file 9:
Dataset S1). Interestingly, 60 protein families detected in all
mice using the contig-based DB (16 % of total identification
Fig. 5 Firmicutes/Bacteroidetes ratio in human and mouse subjects measured using different databases. Results obtained with human (N = 3, left)
and mouse (N = 3, right) samples, with each dot representing a single sample. DBs were made up of reads (dark blue, R-A) or contigs (red, C-A)
from gut metagenomes of all subjects analyzed for each host species, or all bacterial sequences deposited in UniProt (turquoise, UP-B). The annotation
tools used were MEGAN (MEG) and Unipept (Up). *p < 0.05; **p < 0.01; ***p < 0.001 (paired t test)
Fig. 6 Functional annotation of human and mouse gut metaproteomic data obtained using different databases. DBs were made up of reads
(dark blue, R-A) or contigs (red, C-A) from gut metagenomes of all subjects analyzed for each host species, or all bacterial sequences deposited in
UniProt (turquoise, UP-B). a Histograms showing the mean number (N = 3, with error bar indicating standard error of the mean) of non-redundant
peptides identified (tot) and annotated at different levels (PF protein family; KO KEGG ortholog; EC enzyme code; BP Gene Ontology Biological
Process; PW pathway; *p < 0.05; **p < 0.01; ***p < 0.001; paired t test) in human (left) and mouse (right) samples upon a blastp against bacterial
Swiss-Prot entries. b PCA plots of function abundances, with each dot indicating a different human (left) or mouse (right) subject
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achieved using that DB) were not detected at all when using
one or both the other DBs.
Discussion
Many different data analysis strategies have been used in
the gut metaproteomic studies published so far [16, 25–28],
but a consensus has not been reached on which could be
considered as the best performing DB search and annota-
tion pipeline. To tackle this issue, here, we performed a
systematic investigation aimed at evaluating the impact of
sequence DB construction and annotation methods on gut
metaproteomic results.
Since most gut microbiota investigations involve either
human subjects or animal experimental models, we de-
cided to analyze both human and mouse fecal samples.
In view of the large heterogeneity observed in human
populations [29] and a lower inter-individual diversity
expected in syngenic mice [30], we hypothesized that
human and mouse model metaproteomic studies would
require dedicated data analysis strategies. In this respect,
we demonstrate that the choice of performing shotgun
metagenome sequencing to generate sample-matched
(or, as suggested by these results, “population”-matched)
DBs can considerably improve metaproteomic results,
but this occurs with a considerably different magnitude
in the two microbiota under study. In fact, a dramatic-
ally higher increase in terms of general identification
yield and annotation depth can be observed in mouse
when using a metagenomic DB instead of a UniProt-
based DB. A possible explanation of this might reside in
the considerably lower number of sequenced microbial
strains among those colonizing the gut of mouse models,
compared to the extensively studied microbes inhabiting
the human gut. Consequently, the impact of this issue is
expected to decrease as the number of sequences from
the mouse gut metagenome grows in the years to come.
When considering these results, special attention should
be paid when selecting a DB for the analysis of a non-
human gut microbiota, since uncritically applying data
analysis pipelines optimized for human samples may
lead to unexpectedly poor results.
Concerning the influence of metagenomic sequence
assembly on metaproteomic analysis, our data also provide
evidences that the choice between read- or contig-based
DB considerably affects identification and annotation
yields. Noteworthy, contigs clearly outperformed reads
both for taxonomic and functional annotation yields, at
least when annotation was carried out using blast-based
methods. In particular, the association of contigs with
MEGAN reached the best results in terms of taxonomic
annotation yield, although in a previous study per-
formed using lab-assembled microbial mixtures higher
amounts of false positives were achieved when employ-
ing MEGAN for LCA classification instead of Unipept
[15]. Clearly, the generation of DBs based on longer
reads and contigs, stemming from the continuous im-
provement of pyrosequencing and sequencing by synthesis
technologies, will further ameliorate both taxonomic and
functional annotation yields.
With reference to UniProt-derived DBs, our data dem-
onstrate that the advantage of performing a taxonomy-
based sequence selection in order to obtain smaller-size
DBs (essentially with the aim of reducing size-related
FDR estimation issues) is clearly dependent on the par-
ticular combination of search engine and FDR calcula-
tion tool used. In more detail, merging information from
Fig. 1 and Table 1 reveals that DB size-related issues ap-
pear to be stronger with X!Tandem/qvality, and almost
negligible with Sequest-HT/Percolator. In many cases,
however, the generation of a pseudo-metagenome based
on taxonomic results from 16S rDNA analysis might be
the preferred way—in the absence of matched shotgun
metagenomes—to avoid huge analysis times (especially
with MaxQuant) related to the use of the whole UniProt-
bacteria DB. Besides size-related issues, taxonomic annota-
tion was revealed to be strongly divergent when using a
UniProt-based DB compared to MG-DBs (as exemplified
by the Firmicutes/Bacteroidetes ratio), possibly due to biases
in the number of deposited sequences within and among
different phyla (as an example, Firmicutes entries are 3.5
times more represented than Bacteroidetes in the 2016_02
release of UniProt).
One of the main messages that can be inferred from our
findings is that searching against different DB types and
merging the related results can significantly deepen taxo-
nomic and functional characterization of the gut metapro-
teome. The complementary nature of results, as well as the
presence of DB-specific biases, suggests that the use of mul-
tiple DBs can likely lead to a more detailed and balanced
picture of the biological activities exerted by intestinal mi-
crobial communities. Conversely, merging different types of
sequences (e.g., reads and contigs) in a single DB led to
lower identification yields compared to multiple parallel
searches (data not shown). Although the advantage of using
multiple search engines has been repeatedly demonstrated
and highlighted [11, 31], the parallel use of multiple DBs
has been much less frequently proposed as a systematic
strategy [32, 33]. Similar considerations may be made with
regard to taxonomic annotation tools, as a low amount of
peptides were annotated both by MEGAN and Unipept
(down to 15 % in mouse, data not shown); thus, most pep-
tides were annotated by a single tool only, probably as a
consequence of substantial differences between the two
taxonomic classification algorithms. Under a general and
practical perspective, the data analysis design of a gut
microbiota investigation should aim for a compromise be-
tween sensitivity and information depth, on the one hand,
and computational and time effort, on the other hand.
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Conclusions
This study contributes to identify host- and database-
specific biases which need to be taken into account in a
metaproteomic experiment, providing meaningful in-
sights on how to design gut microbiota studies and to
perform bioinformatic analysis of metaproteomic data.
Specifically, the following recommendations can be made
based on the data presented in this work: (i) coupling ex-
perimental metagenomic sequencing to metaproteomic
analysis for DB construction purposes is mandatory when
dealing with a non-human gut microbiota, but useful also
for human studies; (ii) assembling reads into longer con-
tigs may considerably enhance taxonomic and, even more,
functional annotation; (iii) the use of multiple DBs and
annotation tools has to be encouraged, even though this
requires appropriate bioinformatic resources; (iv) the use
of a “merged” DB, containing all metagenomic sequences
from the population under study, is preferable over the
use of sample-matched DBs; and (v) comparing results ob-
tained with different DBs or tools should be carefully
avoided, as it may lead to erroneous and unreliable con-
clusions. In keeping with these issues, the gut microbiota
research community would greatly benefit from the devel-
opment of specific bioinformatic applications facilitating
browsing, selection, processing, merging, and annotation
of sequencing data for metaproteomics.
Methods
Samples
Human stool samples were collected from four healthy
Sardinian volunteers, who gave their informed consent
for using the biological material for research purposes.
Mouse stool samples (kindly provided by Dr. Michael
Silverman, Mathis-Benoist Laboratory, Department of
Microbiology and Immunobiology, Harvard Medical
School, USA) were collected from three 10-week-old
NOD mice. All samples were immediately stored at −80 °C
until use. Then, samples were thawed at 4 °C, and from
each of them two equal stool fragments (weighing approxi-
mately 250 and 30 mg for human and mouse samples,
respectively) were collected: the first underwent DNA
extraction for metagenomic analysis, and the second was
subjected to protein extraction for metaproteomic analysis.
DNA sample preparation and metagenome sequencing
DNA extraction was carried out using QIAamp Fast
Stool Kit protocol (QIAGEN, Hilden, Germany). The ex-
tracted DNA was quantified on a Qubit 2.0 Fluorometer
(Life Technologies, Grand Island, NY, USA), using the
Qubit dsDNA High Sensitivity Assay Kit (Life Technolo-
gies). 16S rRNA gene amplification was performed using
the universal primers 27F-1492R [34]. Two separate 16S
rRNA gene amplification reactions were performed,
pooled together, cleaned up using AMPure XP (Beckman
Coulter, Brea, CA, USA) magnetic beads, and quantified
with Qubit HS assay (Life Technologies). Libraries were
constructed according the Illumina Nextera XT sample
preparation protocol (Illumina, San Diego, CA, USA).
Normalized sample libraries were pooled and subjected to
the cluster generation step using the cBOT cluster gener-
ation station, according to the Illumina TruSeq Paired-
End Cluster Kit protocol (Illumina). DNA sequencing was
performed with the Illumina HiScanSQ sequencer, using
the paired-end method and 93 cycles of sequencing. After
sequencing, all reads were subjected to a demultiplexing
step using Casava, v.1.8.2.
Metagenome bioinformatics
16S data were processed using QIIME software package,
v.1.8 [35]. The Illumina paired-reads were trimmed for
the first 20 bp, and the sequences contaminated with
Nextera adapters were identified using the UniVec data-
base and removed. Therefore, the paired-reads with a
minimum overlap of eight bases were merged and then
filtered (first position quality score >15). Singletons were
filtered with the same settings and added to the merged
sequences that were clustered into OTUs at 97 % iden-
tity level against the Greengenes database (v.13_8)
obtaining the BIOM table used to generate the pseudo-
metagenomes. Concerning whole metagenome process-
ing, raw reads were either filtered and clustered without
assembly, or assembled de novo into contigs. In the first
case, read processing was carried out using tools from
the USEARCH suite v.8.0.1623 [36, 37]. Specifically, the
following steps were performed sequentially: merging of
paired reads (fastq_mergepairs command, setting param-
eters as follows: fastq_truncqual 3, fastq_minovlen 8, fas-
tq_maxdiffs 0), quality filtering (fastq_filter command,
with fastq_truncqual 15 and fastq_minlen 100), and se-
quence clustering (cluster_smallmem command, with 1
as identity threshold). In the second case, read assembly
into contigs was carried out using Velvet v.1.2.10 [38],
by setting 61 as k-mer length, 200 as insert length, and
300 as minimum contig length. ORF finding was carried
out using FragGeneScan v.1.19 [39], training for Illumina
sequencing reads with about 0.5 % error rate. Six-frame
translation (6FT) was performed using the six-frame
translation tool embedded in Max Quant v.1.5.2.8 [40],
with 20 as minimum amino acid sequence length.
Protein sample preparation and mass spectrometry
analysis
Samples were resuspended by vortexing in SDS-based
extraction buffer and then heated and subjected to a
combination of bead-beating and freeze-thawing steps as
detailed elsewhere [41]. Protein extracts were subjected
to on-filter reduction, alkylation, and trypsin digestion
according to the filter-aided sample preparation (FASP)
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protocol [42], with slight modifications detailed elsewhere
[20, 43]. LC-MS/MS analysis was carried out using an
LTQ-Orbitrap Velos mass spectrometer (Thermo Scien-
tific, San Jose, CA, USA) interfaced with an UltiMate 3000
RSLCnano LC system (Thermo Scientific). The single-run
1D LC peptide separation was performed as previously
described [41], loading 4 μg of peptide mixture per each
sample and applying a 485-min (murine samples) or 153-
min (human samples) separation gradient. The mass spec-
trometer was set up in a data dependent MS/MS mode,
with higher-energy collision dissociation as the fragmenta-
tion method, as illustrated elsewhere [43].
Metaproteome bioinformatics
Peptide identification was carried out using three bioinfor-
matic platforms: MetaProteomeAnalyzer (MPA; v.1.0.6)
[44], MaxQuant (MQ; v.1.5.2.8) [40], and Proteome Discov-
erer™ (PD; v.1.4.1.14; Thermo Scientific). For MPA analysis,
X!Tandem [45] was used as search engine (precursor ion
tolerance 10 ppm, fragment ion tolerance 0.02 Da, max
missed cleavages 2, plus default search parameters) and
qvality [46] as validation tool. For MQ analysis, carbamido-
methylation of cysteine was set as fixed modification and
oxidation of methionine as variable modification, and the
other parameters were set as default. For PD analysis,
Sequest-HT was used as search engine and Percolator [47]
as validation tool, with all parameters set as described pre-
viously [20]. Two different false discovery rate thresholds
were set for comparison, namely at 5 and 1 %.
DB construction was carried out as illustrated in Fig. 1.
Human and murine MG-DBs were built on experimental
sequences, after processing described in the “Metagenome
bioinformatics” section. UniProt-based DBs were built on
bacterial sequences retrieved from UniProt (Swiss-Prot
+TrEMBL, release 2014_12). 16S-based DBs contained
UniProt sequences (directly retrieved from the UniProt
website) belonging to 17 families (namely, Bacteroidaceae,
Ruminococcaceae, Lachnospiraceae, Porphyromonadaceae,
Paraprevotellaceae, Barnesiellaceae, Veillonellaceae, S24-7,
Clostridiaceae, Rikenellaceae, Odoribacteraceae, Alcaligen-
aceae, Prevotellaceae, Christensenellaceae, Victivallaceae,
Verrucomicrobiaceae, Erysipelotrichaceae), 21 genera
(namely, Bacteroides, Ruminococcus, Faecalibacterium,
Parabacteroides, Oscillospira, Lachnospira, Phascolarcto-
bacterium, Coprococcus, Prevotella, Blautia, Sutterella,
Clostridium, Dialister, Lachnobacterium, Ruminococcus,
Butyricimonas, Odoribacter, Akkermansia, 5-7N15, Anae-
rostipes, Roseburia), or 19 species (namely, Faecalibacter-
ium prausnitzii, Bacteroides fragilis, Bacteroides plebeius,
Parabacteroides distasonis, Bacteroides uniformis, Bacter-
oides ovatus, Akkermansia muciniphila, Bacteroides
eggerthii, Bacteroides caccae, Bacteroides coprophilus,
Ruminococcus gnavus, Bacteroides barnesiae, Ruminococcus
bromii, Ruminococcus flavefaciens, Desulfovibrio D168,
Ruminococcus callidus, Blautia producta, Prevotella mela-
ninogenica, Prevotella nigrescens) identified upon QIIME
analysis of 16S rRNA sequencing data (abundance thresh-
old 0.1 %). Proteomic iterative (PI) DBs were generated
according to a taxonomy-based iterative strategy described
earlier [15, 20]. Specifically, peptide sequences identified
upon database search against UniProt-Bacteria were
uploaded into the “Metaproteomics Analysis” module of
the Unipept web application (v.2.5) [48] to carry out a taxo-
nomic assignment based on the lowest common ancestor
(LCA) approach, applying the following settings: “Equate I
and L,” “Filter duplicate peptides,” and “Advanced missed
cleavage handling”. Based on Unipept classification (abun-
dance threshold 0.5 %), sequences belonging to specific
families (namely, Ruminococcaceae, Bacteroidaceae, Clostri-
diaceae, Eubacteriaceae, Lachnospiraceae, Prevotellaceae,
Bifidobacteriaceae, Sutterellaceae, Acidaminococcaceae,
Porphyromonadaceae, Akkermansiaceae, and Desulfovibrio-
naceae, plus Oscillospiraceae, Rikenellaceae, and Enterobac-
teriaceae for PD analysis only), genera (namely,
Faecalibacterium, Bacteroides, Clostridium, Eubacterium,
Subdoligranulum, Prevotella, Ruminococcus, Roseburia,
Phascolarctobacterium, Bifidobacterium, Sutterella, and
Akkermansia, plus Oscillibacter and Alistipes for PD ana-
lysis only), or species (namely, Faecalibacterium prausnitzii,
Subdoligranulum variabile, Bacteroides plebeius, Bacter-
oides uniformis, Bacteroides vulgatus, Sutterella wads-
worthensis, Bacteroides dorei, [Eubacterium] eligens,
Akkermansia muciniphila, Bacteroides massiliensis, Rumi-
nococcus bromii, Ruminococcus bicirculans, Bacteroides cel-
lulosilyticus, Bilophila wadsworthia, Alistipes putredinis,
and Phascolarctobacterium succinatutens, plus Parasutter-
ella excrementihominis for MPA analysis only, and Bacter-
oides thetaiotaomicron for MQ and PD analyses only) were
retrieved from UniProt.
Taxonomic annotation of metaproteomic data was
carried out using MEGAN (v.5.9) [49] and Unipept.
For MEGAN analysis, read, contig, and protein se-
quences (identified from each respective DB) were
subjected to blastp search against the NCBI-nr DB
(e-value threshold 10−5), and LCA was performed on
blast results using default parameters. For Unipept
analysis, peptide sequences were uploaded in the
Metaproteomics Analysis module and classified using
the above described settings.
Functional annotation was accomplished by blastp search
(e-value threshold 10−5) against bacterial sequences from
the UniProt/Swiss-Prot database (release 2014_12) and sub-
sequent retrieval of protein family, KEGG orthologous
groups, enzyme codes, Gene Ontology biological processes,
and pathway information associated with each UniProt/
Swiss-Prot accession number [50].
Shannon’s index for alpha diversity estimation was calcu-
lated according to established methods [51]. Differentially
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abundant features were identified by linear discriminant
analysis and effect-size calculation using LEfSe [20, 52],
with the following significance thresholds: log LDA
score >2; alpha-value <0.05. Cladograms were generated by
LEfSe and modified using Inkscape (https://inkscape.org),
and histograms and dot plots were generated using
GraphPad Prism (v.5.03), and Venn diagrams were gen-
erated using Venny (v.2.1.0; http://bioinfogp.cnb.csic.es/tools/
venny/index.html) and Venn Diagram Plotter (v.1.5.5228;
https://omics.pnl.gov/software/venn-diagram-plotter). Princi-
pal component analysis (with singular value decomposition
and imputation of missing data) was carried out using Clust-
Vis [53]. Statistical significance of differences was assessed by
applying a paired t test.
Additional files
Additional file 1: Figure S1. (A) The influence of the ORF finding
approach on metagenomic databases. Venn diagrams indicate overlap
among non-redundant peptide identifications obtained using ORFs found
by FragGeneScan (FGS) or six-frame translation (6FT) as sequence databases.
Percentage increase related to the use of a 6FT database in addition to the
corresponding FGS database is shown on the bottom-right of each Venn
diagram. Metagenomic databases derive from a 6-Mbps metagenome.
Peptide identifications were obtained at 5 % FDR, using three different
bioinformatic platforms (left, MetaProteomeAnalyzer; middle, MaxQuant;
right, Proteome Discoverer) with the corresponding (and above indicated)
search engines and peptide validation tools. (B) Comparison between reads-
and contigs-based metagenomic databases at different sequencing depths.
Venn diagrams indicate overlap among non-redundant peptide identifications
obtained using reads (R) or assembled contigs (C) as sequence databases.
ORFs from both reads and contigs were found by FragGeneScan (F).
Metagenome sequencing depth was 18 (top), 6 (middle), or 3 (bottom)
Mbps. Percentage increase related to the use of contigs-based database
in addition to the corresponding reads-based database is shown in red
on the bottom-right of each Venn diagram, while percentage increase
related to the use of reads-based database in addition to the corresponding
contigs-based database is shown in blue on the bottom-left of each Venn
diagram. Peptide identifications were obtained at 5 % FDR, using three
different bioinformatic platforms (left, MetaProteomeAnalyzer; middle,
MaxQuant; right, Proteome Discoverer) with the corresponding (and
above indicated) search engines and peptide validation tools. (TIF 2050 KB)
Additional file 2: Figure S2. The influence of taxonomic filter level on
the 16S-based (16S, top) and proteomic iterative (PI, bottom) databases.
Venn diagrams indicate overlap among non-redundant peptide identifications
obtained using UniProt sequences belonging to all families (F), genera (G), or
species (S) detected after 16S rDNA gene sequencing and QIIME taxonomic
assignment (16S; taxon abundance threshold >0.1 %), or a preliminary search
against UniProt Bacteria and peptide taxonomic assignment using Unipept
(PI; taxon abundance threshold >0.5 %). Peptide identifications were
obtained at 5 % FDR, using three different bioinformatic platforms
(left, MetaProteomeAnalyzer; middle, MaxQuant; right, Proteome Discoverer)
with the corresponding (and above indicated) search engines and peptide
validation tools. (TIF 1580 KB)
Additional file 3: Figure S3. Complementarity between reads-based
database and other database types. Venn diagrams indicate overlap
among non-redundant peptide identifications obtained using different
sequence databases (see Additional file 1: Figure S1 and Additional file 2:
Figure S2 for further details). Percentage increase related to the use of a
given database in addition to the counterpart is shown on the bottom,
on the same side and in the same color. Peptide identifications were
obtained at 5 % FDR, using three different bioinformatic platforms (left,
MetaProteomeAnalyzer; middle, MaxQuant; right, Proteome Discoverer)
with the corresponding (and above indicated) search engines and peptide
validation tools. (TIF 1780 KB)
Additional file 4: Figure S4. Alpha-diversity values measured in human
(A) and mouse (B) samples according to Shannon’s index. Dark blue,
database comprising reads from gut metagenomes of all subjects analyzed
for that host species; red, database comprising contigs assembled
from gut metagenomes of all subjects analyzed for that host species;
turquoise, all bacterial sequences deposited in UniProt (UP-B). *p < 0.05;
**p < 0.01. (TIF 349 KB)
Additional file 5: Figure S5. Histograms illustrating the number of taxa
identified with the three DBs in human (left) and mouse (right) samples,
distinguishing qualitatively differential (black), quantitatively differential
(white) and non-differential (grey) taxa. (TIF 648 KB)
Additional file 6: Figure S6. Cladograms illustrating human gut
microbiota taxa detected with differential abundance when using
different sequence databases. Spectral counting data obtained upon
Sequest-HT/Percolator search (1 % FDR) and MEGAN (left) or Unipept
(right) lowest common ancestor (LCA) taxonomic classification were
uploaded into LEfSe for differential analysis and cladogram construction.
Taxa with higher abundance related to a given database are marked with
the specific database color (dark blue, reads-based MG-DB; red, contigs-
based MG-DB; turquoise, UniProt Bacteria). (TIF 3450 KB)
Additional file 7: Figure S7. Cladograms illustrating mouse gut
microbiota taxa detected with differential abundance when using
different sequence databases. Spectral counting data obtained upon
Sequest-HT/Percolator search (1 % FDR) and MEGAN (left) or Unipept
(right) lowest common ancestor (LCA) taxonomic classification were
uploaded into LEfSe for differential analysis and cladogram construction.
Taxa with higher abundance related to a given database are marked with
the specific database color (dark blue, reads-based MG-DB; red, contigs-
based MG-DB; turquoise, UniProt Bacteria). (TIF 7330 KB)
Additional file 8: Figure S8. Histograms illustrating the number of
protein families identified with the three DBs in human (left) and mouse
(right) samples, distinguishing qualitatively differential (black), quantitatively
differential (white) and non-differential (gray) features. (TIF 247 KB)
Additional file 9: Dataset S1. Lists of protein families detected with
significantly varying abundance when using different DB types in human
and mouse samples. (XLSX 28.0 KB)
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